Arteriovenous Fistula

An arteriovenous fistula is an abnormal connection between an artery and a vein that bypasses the normal capillary network, allowing blood to flow directly from the high-pressure arterial system into the low-pressure venous system. In healthy dogs, blood flows from arteries through progressively smaller vessels until reaching tiny capillaries where oxygen and nutrients exchange with tissues before draining into veins. When an arteriovenous fistula exists, this orderly flow is disrupted, causing blood to take a shortcut that can have significant hemodynamic consequences. These vascular abnormalities can occur anywhere in the body but are most commonly identified in the limbs, liver, and head and neck region in dogs.

The pathophysiology of arteriovenous fistulas involves the shunting of blood from the arterial system directly into veins without passing through the resistance-providing capillary bed. This abnormal pathway creates several problems including increased blood flow through the affected area, elevated pressure in the venous system receiving the shunted blood, and reduced blood flow to tissues downstream from the fistula. The heart must work harder to maintain adequate circulation, as blood continuously cycles through the low-resistance fistula rather than perfusing tissues effectively. Over time, the increased cardiac workload can lead to heart enlargement and potentially heart failure if the fistula is large or has been present for an extended period.

Arteriovenous fistulas in dogs may be congenital, present from birth due to developmental abnormalities in blood vessel formation, or acquired through trauma, surgery, or other injury to blood vessels. Congenital forms often involve the liver, where hepatic arteriovenous fistulas can cause significant clinical problems, or may occur in the limbs or other locations. Acquired fistulas typically result from penetrating injuries, surgical complications, or other trauma that creates an abnormal connection between adjacent arteries and veins. The clinical presentation varies widely depending on the location, size, and duration of the fistula, ranging from incidental findings to life-threatening complications.

Diagnosis and treatment of arteriovenous fistulas require specialized imaging and often surgical or interventional expertise. Clinical signs may prompt investigation, or fistulas may be discovered during evaluation for other problems. Advanced imaging techniques including Doppler ultrasound, computed tomography angiography, and conventional angiography help characterize the abnormal vascular connections and plan treatment. Treatment options include surgical ligation or excision, interventional embolization procedures, or in some cases careful monitoring when risks of treatment outweigh benefits. Veterinary specialists including surgeons and cardiologists play important roles in managing these complex vascular abnormalities, working to restore normal blood flow patterns and prevent long-term cardiac consequences.

The causes of arteriovenous fistulas in dogs fall into two main categories: congenital malformations present from birth and acquired lesions developing later in life due to injury or disease. Congenital arteriovenous fistulas result from errors during embryonic vascular development when the primitive vascular plexus fails to properly differentiate into separate arterial and venous channels. During normal development, the early blood vessel network remodels to create distinct arteries and veins connected only through capillaries. When this process goes awry, persistent abnormal connections between arterial and venous structures remain, creating congenital fistulas that may be present as single communications or complex networks of abnormal vessels.

Genetic factors may contribute to some congenital arteriovenous malformations, though specific inherited patterns have not been definitively established in dogs. Some evidence suggests familial clustering of hepatic arteriovenous fistulas, raising the possibility of hereditary predisposition. Research in humans has identified genetic mutations affecting vascular development that cause similar malformations, and analogous mechanisms may exist in dogs. Certain breeds have been reported to show higher incidence of specific types of arteriovenous fistulas, though whether this reflects true genetic predisposition or ascertainment bias remains unclear. Further research is needed to clarify the genetic contributions to congenital vascular malformations in dogs.

Acquired arteriovenous fistulas develop when trauma or other injury creates an abnormal connection between adjacent arteries and veins. Penetrating wounds from bites, gunshots, or sharp objects can simultaneously damage an artery and vein, leading to fistula formation during healing. Surgical procedures may inadvertently create fistulas if nearby vessels are injured and heal with abnormal connections. Bone fractures can lacerate adjacent vessels, particularly in areas where arteries and veins run closely together. The high pressure in arteries tends to direct blood through any available low-resistance pathway, encouraging fistula development when vessel walls are breached. Iatrogenic fistulas from catheterization procedures, though rare, have been reported in veterinary patients.

The location of arteriovenous fistulas significantly influences their clinical behavior and consequences. Hepatic arteriovenous fistulas occur within the liver, shunting blood between hepatic arteries and portal or hepatic veins and causing portal hypertension, ascites, and hepatic dysfunction. Peripheral fistulas in the limbs cause local swelling, warmth, and tissue changes while potentially affecting overall cardiac function. Head and neck fistulas may create visible pulsatile masses and can affect surrounding structures. Pulmonary arteriovenous fistulas, though rare, allow blood to bypass the lungs without oxygenation. The specific anatomical location determines which tissues are affected by blood stealing and venous congestion, shaping the clinical presentation and treatment approach.

Secondary effects of arteriovenous fistulas develop as the cardiovascular system responds to the abnormal blood flow patterns. The heart initially compensates for the low-resistance shunt by increasing output, leading to high-output cardiac failure in severe or long-standing cases. The venous system receiving shunted blood experiences elevated pressure, causing dilation, valve damage, and tissue congestion. Tissues downstream from the fistula may become ischemic from blood stealing. Local effects include warmth, swelling, and tissue changes in the region of the fistula. These secondary consequences often produce the clinical signs that lead to diagnosis, sometimes long after the fistula originally formed.

Early warning signs of arteriovenous fistulas often appear subtle and develop gradually, making initial recognition challenging. Owners might notice slight swelling or warmth in an affected limb that seems out of proportion to any known injury. Unexplained fatigue or exercise intolerance may develop as the heart begins to work harder to compensate for blood shunting through the fistula. Puppies with congenital hepatic fistulas may show slower growth or failure to thrive compared to littermates. Changes in coat quality or skin condition over an affected area might be observed. These early signs are often attributed to other causes or dismissed as insignificant variations before the underlying vascular problem is recognized.

Common symptoms of peripheral arteriovenous fistulas in the limbs include noticeable swelling, increased warmth, and visible vascular changes in the affected area. The affected limb typically feels warmer than the opposite side due to increased blood flow through the fistula. Visible dilated veins may appear as the venous system accommodates the excess blood flow. A palpable thrill, which feels like a vibration or buzzing sensation, can often be detected over the fistula site. Using a stethoscope, a characteristic continuous machinery-like murmur may be heard over the lesion. Lameness or reluctance to use the affected limb may develop as tissue changes progress. In severe cases, skin ulceration or tissue breakdown can occur due to venous congestion and inadequate tissue nutrition.

Behavioral changes associated with arteriovenous fistulas reflect both local discomfort and systemic effects of the abnormal blood flow. Dogs may lick or chew at the affected area if local tissue changes cause discomfort or altered sensation. Decreased activity and reluctance to exercise develop as cardiac compensation becomes strained. Affected dogs may seek cool surfaces if increased blood flow creates uncomfortable warmth in the affected region. Appetite changes and weight fluctuations may occur, particularly with hepatic fistulas affecting liver function. Restlessness or difficulty settling comfortably might be observed if the fistula causes pain or discomfort. Changes in normal behavior patterns often precede more obvious physical symptoms.

Physical signs visible during examination provide important diagnostic clues for arteriovenous fistulas. Localized swelling with associated warmth characterizes peripheral fistulas. Pulsatile masses may be visible or palpable in some locations. Visible venous dilation and engorgement appear in the affected region. Abdominal distension from fluid accumulation may develop with hepatic fistulas causing portal hypertension. Signs of heart failure including increased respiratory rate, cough, and exercise intolerance may appear with large or long-standing fistulas. Affected limbs may show trophic changes including hair loss, skin discoloration, or ulceration. In severe cases, cyanosis may be present if cardiac compensation fails.

Symptom progression in dogs with untreated arteriovenous fistulas follows a generally predictable pattern as the cardiovascular system decompensates over time. Local symptoms at the fistula site typically worsen gradually, with increasing swelling, more prominent vascular changes, and progressive tissue effects. Cardiac symptoms develop as the heart enlarges and begins to fail from the chronic volume overload. Exercise tolerance progressively decreases as cardiovascular reserve diminishes. Dogs with hepatic fistulas may develop worsening ascites, hepatic encephalopathy, or gastrointestinal bleeding from portal hypertension. The rate of progression varies depending on fistula size, location, and individual compensatory ability.

Certain symptoms associated with arteriovenous fistulas require immediate emergency veterinary care. Sudden collapse or severe weakness may indicate acute cardiac decompensation or hemorrhage. Severe difficulty breathing suggests heart failure or pulmonary complications requiring urgent intervention. Massive swelling with skin changes indicating tissue compromise needs immediate attention. Bleeding from a peripheral fistula, especially following trauma, requires emergency evaluation. Signs of hepatic encephalopathy including disorientation, seizures, or behavior changes in dogs with known hepatic fistulas warrant immediate care. Any sudden worsening of previously stable symptoms should prompt urgent veterinary consultation to assess for complications requiring intervention.

The diagnostic process for arteriovenous fistulas begins with careful physical examination prompted by clinical signs or incidental findings suggesting vascular abnormality. The veterinarian will assess the affected area for characteristic findings including warmth, swelling, palpable thrill, and audible bruit. Comparison with the opposite limb helps identify unilateral changes suggesting localized vascular pathology. Cardiac auscultation evaluates for murmurs or rhythm abnormalities that might indicate cardiovascular effects of a fistula. Abdominal palpation assesses for hepatomegaly, splenomegaly, or fluid accumulation that might accompany hepatic fistulas. A thorough history regarding any known trauma helps distinguish congenital from acquired lesions.

Imaging studies play the central role in confirming arteriovenous fistulas and characterizing their anatomy for treatment planning. Doppler ultrasound provides non-invasive assessment of blood flow patterns, readily demonstrating the abnormal high-velocity turbulent flow characteristic of arteriovenous shunting. Echocardiography evaluates cardiac size and function, identifying volume overload changes that develop with significant fistulas. Abdominal ultrasound helps identify hepatic fistulas and assess for portal hypertension and ascites. Computed tomography angiography provides detailed three-dimensional visualization of the vascular anatomy, essential for surgical planning. Conventional angiography, though more invasive, offers real-time imaging and the opportunity for simultaneous interventional treatment through catheter-based embolization.

Laboratory testing helps evaluate systemic effects and overall health status in dogs with arteriovenous fistulas. Complete blood count may reveal anemia from chronic blood loss or altered red blood cell production. Chemistry panel assesses liver function in dogs with hepatic fistulas and evaluates kidney function. Coagulation testing may be performed prior to surgical or interventional treatment. Blood gas analysis helps assess oxygenation status if pulmonary fistulas are suspected. These tests also help identify concurrent conditions that might affect treatment decisions or anesthetic risk.

Differentiating arteriovenous fistulas from other vascular and non-vascular conditions requires careful diagnostic evaluation. Hemangiomas and hemangiosarcomas may present as vascular masses requiring differentiation through imaging and sometimes biopsy. Venous malformations and varices appear similar but lack the high-flow characteristics of arteriovenous fistulas. Abscesses and other soft tissue swellings may mimic peripheral fistulas until imaging reveals their true nature. Congestive heart failure from other causes must be distinguished from high-output failure due to fistulas. Hepatic causes of ascites other than fistulas, including portosystemic shunts and liver disease, require differentiation. The characteristic imaging findings and physical examination features usually allow confident diagnosis of arteriovenous fistulas when present.

Emergency treatment may be necessary for dogs presenting with complications from arteriovenous fistulas including heart failure, bleeding, or severe tissue compromise. Stabilization of cardiovascular status takes priority, with oxygen supplementation, diuretics for heart failure, and circulatory support as needed. Active bleeding from traumatic fistulas requires pressure application and volume resuscitation while arrangements for definitive treatment are made. Drainage of large-volume ascites may provide temporary relief in dogs with hepatic fistulas causing respiratory compromise. Pain management ensures patient comfort during stabilization. Emergency surgery may be needed for uncontrolled hemorrhage or rapidly deteriorating clinical status.

Surgical treatment remains the definitive approach for many arteriovenous fistulas, aiming to eliminate the abnormal vascular connection while preserving normal blood supply to affected tissues. Surgical ligation involves tying off the vessels feeding and draining the fistula, interrupting the abnormal flow. Complete excision removes the fistula and surrounding abnormal vessels when anatomically feasible. Amputation may be considered for peripheral limb fistulas when other approaches are not possible or have failed. Hepatic fistulas may require liver lobe resection when the abnormality is confined to a specific region. The complexity of surgery varies with fistula location and anatomy, with some procedures requiring specialized vascular surgical expertise.

Interventional radiologic techniques offer minimally invasive alternatives to traditional surgery for some arteriovenous fistulas. Catheter-based embolization uses various materials delivered through blood vessels to occlude the feeding arteries or the fistula itself. Coils, particles, glue-like substances, or specialized occluding devices can be deployed to block abnormal flow. This approach may be particularly useful for fistulas in locations where surgical access is difficult or risky. Embolization may serve as definitive treatment or as an adjunct to surgery, reducing blood flow before surgical excision. The availability of interventional procedures depends on access to specialized equipment and expertise at veterinary referral centers.

Medical management plays a supportive role in treating arteriovenous fistulas and their complications. Heart failure management with diuretics and other cardiac medications helps control symptoms while definitive treatment is planned. Management of portal hypertension from hepatic fistulas may include dietary modification and medications to reduce ammonia absorption. Pain management ensures comfort during the treatment course. Treatment of secondary complications such as skin ulcers or infections addresses localized problems. Medical therapy alone rarely provides long-term control of significant fistulas but helps stabilize patients for definitive intervention.

Conservative management with monitoring may be appropriate for some small or stable arteriovenous fistulas where treatment risks outweigh benefits. Small congenital fistulas discovered incidentally may remain stable for extended periods without causing significant problems. Acquired fistulas in locations where surgery carries significant risk may be monitored rather than immediately treated. Serial imaging documents stability or progression, guiding decisions about intervention timing. Close attention to developing symptoms prompts treatment if the clinical situation changes. Conservative management requires ongoing veterinary oversight to detect progression before serious complications develop.

Treatment decisions for arteriovenous fistulas involve careful consideration of multiple factors specific to each patient's situation. Fistula size, location, and anatomy influence which treatment approaches are feasible and likely to succeed. Overall patient health and concurrent medical conditions affect anesthetic and surgical risk. Owner factors including ability to pursue referral care, provide post-treatment monitoring, and manage financial aspects influence planning. The potential consequences of untreated progression must be weighed against treatment risks. Consultation with veterinary specialists including surgeons, cardiologists, and interventional radiologists helps clarify options and optimize treatment selection for each individual case.

Recovery timelines following treatment for arteriovenous fistulas vary depending on the type of intervention and the patient's preoperative condition. Dogs undergoing surgical ligation or excision typically require one to two weeks of restricted activity for initial wound healing, with gradual return to normal activity over an additional two to four weeks. Interventional procedures generally involve shorter immediate recovery periods, though monitoring for treatment effectiveness continues for several weeks. Dogs with significant cardiac changes from long-standing fistulas may require extended periods for cardiac remodeling and improvement. Complete resolution of local tissue changes may take months as venous congestion resolves and affected tissues heal.

Post-treatment care requirements focus on wound management, activity restriction, and monitoring for complications or recurrence. Surgical patients need incision care with monitoring for signs of infection, dehiscence, or seroma formation. Activity restriction prevents stress on surgical repairs or dislodgement of embolic materials. Pain management ensures comfort during healing. Follow-up imaging confirms fistula closure and monitors for collateral vessel development that might restore abnormal flow. Serial cardiac evaluation documents improvement in heart size and function following treatment. Medication protocols including any cardiac medications, antibiotics, or pain relief must be followed carefully.

Prognosis following treatment of arteriovenous fistulas depends on several factors including successful elimination of abnormal flow and the degree of reversibility of any secondary changes. Complete surgical excision or successful embolization generally offers excellent prognosis for resolution of the vascular abnormality. Cardiac changes from chronic volume overload often improve or resolve following successful treatment, though severely affected hearts may show persistent abnormalities. Local tissue changes including venous dilation and trophic effects may improve significantly or persist to varying degrees. Hepatic fistulas successfully treated before irreversible liver damage carry better prognosis than those with established cirrhosis. Early treatment before development of significant secondary effects generally predicts better long-term outcomes.

Long-term outlook following treatment emphasizes monitoring for recurrence and managing any persistent effects. Follow-up examinations at regular intervals assess for signs of fistula recurrence or development of new abnormal connections. Cardiac monitoring continues until heart size and function normalize or stabilize. Dogs with treated hepatic fistulas require ongoing liver function monitoring. Activity may return to normal once healing is complete and cardiac function has recovered. Life expectancy for dogs with successfully treated simple fistulas approaches normal, while those with complex malformations or significant secondary damage may face ongoing management needs. Open communication with the veterinary team about expectations and monitoring recommendations supports optimal long-term outcomes.

Prevention of congenital arteriovenous fistulas focuses on breeding considerations for conditions with suspected hereditary components. Avoiding breeding affected dogs or those producing affected offspring helps reduce incidence of congenital vascular malformations within breeding populations. Responsible breeders should track vascular abnormalities in their lines and share information with puppy buyers. Pre-breeding health evaluations help identify dogs with undiagnosed vascular problems. Supporting research into genetic causes of vascular malformations advances understanding that may eventually enable genetic testing and more targeted prevention. Until genetic factors are better understood, careful breeding practices based on family history remain the primary prevention strategy.

Prevention of acquired arteriovenous fistulas centers on avoiding or minimizing traumatic injuries to blood vessels. Supervising dogs during activities with potential for penetrating injuries reduces risk of trauma that could damage adjacent arteries and veins. Prompt veterinary attention for wounds, especially deep punctures or lacerations in areas with major blood vessels, ensures proper evaluation and treatment. Careful surgical technique during procedures near major vessels minimizes risk of iatrogenic fistula formation. Proper healing of wounds and fractures with appropriate veterinary care reduces the chance of abnormal vascular connections developing. Recognition that fistulas can form weeks to months after injury prompts appropriate monitoring of previously injured areas.

Early detection through vigilant monitoring helps prevent complications from developing before treatment. Awareness of the possibility of arteriovenous fistulas helps owners recognize early signs warranting veterinary evaluation. Monitoring of wound healing sites for unusual swelling, warmth, or pulsation enables early detection of developing fistulas. Prompt veterinary consultation for unexplained limb swelling or other suspicious findings leads to timely diagnosis. Routine wellness examinations provide opportunity for detection of heart murmurs or other signs that might indicate unsuspected vascular abnormalities. In breeds with reported increased incidence of vascular malformations, heightened awareness supports early recognition.

Health maintenance and regular veterinary care support early detection of developing problems. Annual wellness examinations include cardiac auscultation that might detect murmurs from cardiac effects of fistulas. Physical examination of the limbs and body surfaces may identify pulsatile masses or other suggestive findings. Discussion of any new symptoms or concerns during veterinary visits enables timely investigation. Understanding that cardiac symptoms might result from vascular abnormalities prompts appropriate diagnostic workup. Building a relationship with your veterinarian facilitates communication about subtle changes that might warrant evaluation.

Early intervention when vascular abnormalities are detected prevents progression to more serious complications. Treatment of smaller fistulas before cardiac changes develop offers better outcomes than waiting until heart failure occurs. Addressing acquired fistulas promptly after injury reduces the chance of permanent vascular remodeling. Recognition that some changes may be irreversible emphasizes the importance of early diagnosis and treatment. Working with veterinary specialists ensures access to appropriate diagnostic and treatment options. Understanding that watchful waiting carries risks of progression helps inform decisions about treatment timing.

Daily management of a dog with an arteriovenous fistula depends on whether the condition is being monitored conservatively or managed following treatment. Dogs under observation require regular assessment of the affected area for changes in size, warmth, or appearance. Monitoring activity tolerance helps identify cardiac effects requiring intervention. Consistent exercise routines appropriate to the dog's cardiovascular status support health without overexertion. Recording observations in a symptom diary provides objective tracking for veterinary consultations. Medication administration as prescribed ensures therapeutic levels of any cardiac or supportive medications. Recognition of warning signs prompting immediate veterinary contact prepares owners to respond appropriately to changes.

Creating an appropriate home environment supports comfort and facilitates monitoring for dogs with arteriovenous fistulas. Easy observation of the affected area helps owners track changes over time. Temperature-controlled environments reduce cardiac workload from thermoregulation. Non-slip flooring provides secure footing if weakness develops. Comfortable resting areas support healing and recovery for dogs after treatment. Elevated food and water dishes may help dogs with cardiac effects. Minimizing stressful situations reduces demands on the cardiovascular system. Planning for veterinary visits including transport arrangements ensures access to needed care.

Maintaining quality of life while managing arteriovenous fistulas involves appropriate activity and continued engagement in enjoyable activities. Understanding the individual dog's exercise tolerance guides activity planning. Shorter, more frequent outings may replace longer activities for dogs with reduced stamina. Low-impact activities provide mental stimulation without cardiovascular strain. Maintaining social interactions with family and other pets supports emotional well-being. Adapting activities to accommodate any limb involvement or physical limitations allows continued participation. Focusing on what the dog can still enjoy maintains positive quality of life during management.

Ongoing monitoring and veterinary communication ensure optimal management throughout the course of living with an arteriovenous fistula. Regular veterinary examinations assess fistula status and overall health. Periodic imaging may be recommended to document stability or detect changes. Prompt communication about new symptoms or concerns enables early intervention when needed. Understanding what changes warrant emergency care versus routine appointment scheduling guides appropriate response. Open discussion about prognosis and expectations helps owners plan for their dog's ongoing care. Building a collaborative relationship with the veterinary team supports best outcomes.

Support for owners managing dogs with arteriovenous fistulas addresses the challenges of ongoing care. Understanding the condition through education from the veterinary team empowers informed decision-making. Connecting with others who have managed similar conditions provides practical insights and emotional support. Recognizing that excellent quality of life is often achievable maintains positive outlook. Planning for potential treatment needs including financial considerations reduces stress. Taking breaks from caregiving when possible prevents burnout. Making informed decisions about treatment and monitoring based on the individual dog's situation and family circumstances ensures appropriate personalized care.

Arteriovenous fistulas can occur in any breed, with congenital forms appearing to have some breed associations though clear genetic patterns have not been established. Some reports suggest German Shepherds may have increased incidence of hepatic arteriovenous fistulas, though this observation requires confirmation with larger studies. Other breeds occasionally mentioned in association with congenital vascular malformations include various large breed dogs, though the evidence base remains limited. Most acquired arteriovenous fistulas result from trauma and occur without breed predilection. The relatively rare occurrence of these vascular abnormalities makes establishing clear breed associations challenging.

Risk factors beyond breed may influence arteriovenous fistula development and outcomes. Young dogs are more likely to present with congenital malformations, while acquired fistulas can occur at any age following trauma. Activity level and lifestyle may influence risk of traumatic fistula formation, with more active outdoor dogs potentially facing greater exposure to penetrating injuries. The anatomical location of vessels affects susceptibility to injury-related fistulas in different body regions. Overall health status influences ability to compensate for the hemodynamic effects of fistulas. Recognition of these factors helps identify dogs who might benefit from closer monitoring.

Screening recommendations for arteriovenous fistulas focus on dogs with suggestive clinical signs rather than routine screening of healthy populations given the rarity of these lesions. Puppies showing poor growth, exercise intolerance, or abdominal distension warrant evaluation for possible hepatic arteriovenous fistulas. Dogs developing localized warmth, swelling, or pulsatile masses should be evaluated for possible peripheral fistulas. Cardiac murmurs without other explanation prompt investigation for possible high-output states including arteriovenous shunting. Post-injury monitoring for development of unusual vascular changes supports early detection of acquired fistulas. Awareness of the condition enables recognition when clinical signs suggest its presence.

Several vascular conditions share features with or commonly co-occur with arteriovenous fistulas in dogs. Portosystemic shunts represent another type of abnormal vascular communication, in this case allowing blood to bypass the liver rather than creating arteriovenous connection. Both conditions can cause similar systemic effects including hepatic dysfunction and require careful diagnostic differentiation. Other vascular malformations including venous malformations and cavernous hemangiomas may occur in dogs with predisposition to vascular abnormalities. High-output cardiac conditions from other causes produce similar cardiovascular effects to those seen with arteriovenous fistulas.

Conditions with similar symptoms to arteriovenous fistulas require differentiation during diagnostic evaluation. Soft tissue tumors including hemangioma and hemangiosarcoma can present as vascular-appearing masses. Abscesses and seromas may cause localized swelling mimicking peripheral fistulas until imaging reveals their nature. Lymphedema causes limb swelling that can appear similar to venous congestion from arteriovenous fistulas. Congestive heart failure from primary cardiac disease produces similar signs to high-output failure from fistulas. Portal hypertension from liver disease other than arteriovenous fistulas causes similar abdominal findings. Accurate diagnosis through appropriate imaging ensures correct identification and treatment.

Complications from arteriovenous fistulas or their treatment require monitoring and may influence management decisions. High-output cardiac failure represents the most significant systemic complication of large or long-standing fistulas. Portal hypertension complications including ascites, hepatic encephalopathy, and gastrointestinal bleeding can develop with hepatic fistulas. Local tissue effects including ulceration, bleeding, and infection may complicate peripheral fistulas. Recurrence following treatment requires monitoring and may necessitate additional intervention. Persistent cardiac changes despite successful fistula closure may require ongoing cardiac management. Recognition of these potential complications guides comprehensive management planning.